CAS: 1158838-45-9

N-(2-Chlorophenyl)-4-[[2-[[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]phenyl]amino]-5-fluoro-4-pyrimidinyl]amino]benzamide is a molecule that has been studied in clinical trials for the treatment of autoimmune diseases. It has also shown efficacy against HIV infection and prostate cancer cells. This drug induces autophagy, which is a process by which cells degrade their own components to recycle nutrients and energy, leading to cell death. N-(2-Chlorophenyl)-4-[[2-[[4-[2-(4-ethyl-1-piperazinyl)-2-oxoethyl]phenyl]amino]-5-fluoro-- 4pyrimidinyl]amino]benzamide has also been shown to induce apoptosis in mouse tumor cells and human cancer cells. This drug inhibits the activation

TCS7010

TCS7010 (Aurora A Inhibitor I) is a novel, potent, and selective inhibitor of Aurora A with IC50 of 3.4 nM in a cell-free assay.